SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTSL.L Regulatory News (TSL)

  • There is currently no data for TSL

Rule 8.3- Tissue Science

14 Mar 2008 16:31

Lady Margaret Ruth Elliot14 March 2008 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION Name of person dealing (Note 1) ADAM & COMPANY (NOMINEES) LIMITED FOR LADY MARGARET RUTH ELLIOT Company dealt in TISSUE SCIENCE LABORATORIES PLC Class of relevant security to which ORDINARY 10P SHARES the dealings being disclosed relate (Note 2) Date of dealing 13 MARCH 2008 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 0 (0.00) 0 (0.00) (2) Derivatives (other than options) 0 (0.00) 0 (0.00) (3) Options and agreements to 0 (0.00) 0 (0.00) purchase/sell Total 0 (0.00) 0 (0.00) (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) SALE 465,909 £1.015 GBP (b) Derivatives transactions (other than options) Product Long/short Number of Price per name, e.g. (Note 6) securities unit (Note 5)CFD (Note 7) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, Expiry Option name,e.g. selling, securities price e.g. date money call purchasing, to which American, paid/ option varying the option European received etc. relates etc. per unit (Note 7) (Note 5) (ii) Exercising Product name, Number of Exercise price per unit e.g. call option securities (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 14 MARCH 2008 Contact name COLIN MOFFAT Telephone number 0131 777 1771 If a connected EFM, name of offeree /offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Nov 20197:01 amRNSIssue of legal proceedings
29th Nov 20197:00 amRNSAGM Statement and Business Update
20th Nov 201911:40 amRNSHolding(s) in Company
13th Nov 20191:25 pmRNSTR1: Standard form for notification major holdings
6th Nov 201910:00 amRNSPosting of Annual Report and Notice of AGM
26th Sep 20197:58 amRNSFinal Results for the year ended 30 June 2019
17th Sep 20197:00 amRNSAppointment of Nominated Adviser and Broker
28th Aug 201912:00 pmRNSSale of 125,000 Afterpay Shares
1st Jul 201911:00 amRNSChange of Auditor
27th Jun 20193:30 pmRNSBoard Changes
27th Jun 20193:00 pmRNSSale of 125,000 Afterpay shares
7th Jun 20197:00 amRNSBusiness Update
9th May 201911:43 amRNSDirector/PDMR Shareholding Notifications
4th Apr 201911:37 amRNSReturn of Capital and Dividend
6th Mar 20197:01 amRNSReturn of Capital and Dividend
6th Mar 20197:00 amRNSInterim Results for 6 months ended 31 Dec 2018
15th Nov 20184:13 pmRNSDirector/PDMR Shareholding Notifications
14th Nov 20181:56 pmRNSResult of AGM and confirmation of Dividend
22nd Oct 20189:09 amRNSPosting of Annual Report and Notice of AGM
19th Sep 20181:21 pmRNSTR1: Standard form for notification major holdings
19th Sep 20187:00 amRNSFinal Results for the year to 30 June 2018
28th Aug 20187:00 amRNSSale of Initial Tranche of Consideration Shares
23rd Aug 20187:00 amRNSDisposal of Shares in ClearPay Finance Limited
7th Jun 20187:00 amRNSThinkSmart Announces Launch of ClearPay with Aurum
18th Apr 20187:00 amRNSChange of Nominated Adviser
5th Apr 20182:31 pmRNSDirectorate Update
22nd Mar 201811:34 amRNSDirector/PDMR Shareholding
12th Mar 20187:00 amRNSChange of Adviser
9th Mar 20184:15 pmRNSPDMR Shareholding Notification
8th Mar 20186:03 pmRNSTR1: Standard form for notification major holdings
7th Mar 20187:00 amRNSInterim Results
12th Feb 20187:00 amRNSTR1: Standard form for notification major holdings
3rd Jan 201812:36 pmRNSDirectorate Change
2nd Jan 20187:00 amRNSTotal Voting Rights
22nd Dec 20177:00 amRNSPDMR Dealings
8th Dec 20175:34 pmRNSPDMR / PCA Shareholdings
1st Nov 20172:10 pmRNSResult of AGM
1st Nov 20177:00 amRNSBusiness Update
9th Oct 20174:19 pmRNSPosting of Annual Report and Notice of AGM
6th Sep 20177:00 amRNSFinal Results for the year to 30 June 2017
2nd Aug 20172:40 pmRNSTR1: Standard form for notification major holdings
1st Aug 20177:00 amRNSTR1: Standard form for notification major holdings
25th May 20177:00 amRNSBusiness Update
23rd May 20177:00 amRNSAppointment of Chief Executive Officer
27th Apr 201712:37 pmRNSManagement Update
5th Apr 20178:48 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
15th Mar 20177:04 amRNSDirector Resignation
15th Mar 20177:00 amRNSInterim Results
27th Feb 20173:53 pmRNSDepositary Interests
8th Feb 20177:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.